While packing for a move, the youngest son of columnist Cazandra Campos-MacDonald experiences a regular guest: joint pain.

Certain immune markers in the blood may help predict ITI response among hemophilia A patients given immune tolerance ...

Like many with hemophilia, columnist G Shellye Horowitz requires IV infusions of her medication — but the scars can raise some eyebrows.

Preventive treatment with Pfizer's Hympavzi can reduce bleeding rates in hemophilia A or B patients with inhibitors, new ...

Directly switching from Hemlibra to Mim8 was well tolerated in people with hemophilia A, with or without inhibitors, a study ...

A study reveals that the majority of Chinese patients with hemophilia A depend on on-demand therapy, resulting in limited ...

Columnist G Shellye Horowitz struggles to find care for her gastrointestinal issues due to the shortage of medical providers ...

The results of gene therapy for hemophilia B contrast with those of factor replacement therapies, where lifelong infusions ...

Hemophilia A treatment While there is no cure for hemophilia A, treatments are available to help manage symptoms, improve life expectancy, and reduce the risk of complications. Hemophilia A treatment ...

Columnist Alliah Czarielle shares how, for her husband, who has hemophilia, finding strength requires acute self-awareness.

Hemophilia type A, sometimes called classic hemophilia, is the most common. It’s caused by a deficiency in FVIII. Hemophilia type B, also known as Christmas Disease, is the second-most common type. It ...

Hemophilia is a rare disorder in which the blood doesn’t clot properly, resulting in the disease’s hallmark symptoms of bleeds — excessive bleeding that extends over a prolonged period of time — that ...